Pang XC - Search Results

1

Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers.

Liu HY, Sun XJ, Xiu SY, Zhang XY, Wang ZQ, Gu YL, Yi CX, Liu JY, Dai YS, Yuan X, Liao HP, Liu ZM, Pang XC, Li TC. Liu HY, et al. Among authors: pang xc. Acta Pharmacol Sin. 2024 Aug;45(8):1556-1570. doi: 10.1038/s41401-024-01270-3. Epub 2024 Apr 17. Acta Pharmacol Sin. 2024. PMID: 38632318 Review.

2

Progress in the development of antiplatelet agents: Focus on the targeted molecular pathway from bench to clinic.

Xiang Q, Pang X, Liu Z, Yang G, Tao W, Pei Q, Cui Y. Xiang Q, et al. Pharmacol Ther. 2019 Nov;203:107393. doi: 10.1016/j.pharmthera.2019.107393. Epub 2019 Jul 26. Pharmacol Ther. 2019. PMID: 31356909 Free article. Review.

3

Targeting integrin pathways: mechanisms and advances in therapy.

Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Pang X, et al. Signal Transduct Target Ther. 2023 Jan 2;8(1):1. doi: 10.1038/s41392-022-01259-6. Signal Transduct Target Ther. 2023. PMID: 36588107 Free PMC article. Review.

4

The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials.

Gu Y, Dong B, He X, Qiu Z, Zhang J, Zhang M, Liu H, Pang X, Cui Y. Gu Y, et al. Pharmacol Res. 2023 Mar;189:106694. doi: 10.1016/j.phrs.2023.106694. Epub 2023 Feb 10. Pharmacol Res. 2023. PMID: 36775082 Free article. Review.

5

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.

He X, Zhang J, Gong M, Gu Y, Dong B, Pang X, Zhang C, Cui Y. He X, et al. Front Immunol. 2023 Jul 10;14:1197275. doi: 10.3389/fimmu.2023.1197275. eCollection 2023. Front Immunol. 2023. PMID: 37492576 Free PMC article.

6

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities.

He X, Wedn A, Wang J, Gu Y, Liu H, Zhang J, Lin Z, Zhou R, Pang X, Cui Y. He X, et al. Pharmacol Res. 2024 Mar;201:107063. doi: 10.1016/j.phrs.2024.107063. Epub 2024 Jan 11. Pharmacol Res. 2024. PMID: 38216006 Free article. Review.

7

Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.

Dong B, Gu Y, Sun X, Wang X, Zhou Y, Rong Z, Zhang J, Shi X, Zhang Z, He X, Chen L, Xiong Q, Pang X, Cui Y. Dong B, et al. Adv Healthc Mater. 2024 Nov;13(28):e2400673. doi: 10.1002/adhm.202400673. Epub 2024 Jun 6. Adv Healthc Mater. 2024. PMID: 38809199

8

Platelet factor 4(PF4) and its multiple roles in diseases.

Liu Z, Li L, Zhang H, Pang X, Qiu Z, Xiang Q, Cui Y. Liu Z, et al. Blood Rev. 2024 Mar;64:101155. doi: 10.1016/j.blre.2023.101155. Epub 2023 Nov 23. Blood Rev. 2024. PMID: 38008700 Review.

9

Osteopontin as a multifaceted driver of bone metastasis and drug resistance.

Pang X, Gong K, Zhang X, Wu S, Cui Y, Qian BZ. Pang X, et al. Pharmacol Res. 2019 Jun;144:235-244. doi: 10.1016/j.phrs.2019.04.030. Epub 2019 Apr 24. Pharmacol Res. 2019. PMID: 31028902 Free article. Review.

10

Mettl1 knockdown alleviates cardiac I/R injury in mice by inactivating the Mettl1-CYLD-P53 positive feedback loop.

Yu ST, Sun ZY, Li N, Qu ZZ, Wang CH, Ju TT, Liu YQ, Mei ZT, Liu KW, Lu MX, Huang M, Li Y, Dou SK, Jiang JH, Zhang YZ, Huang CH, Pang XC, Jia YQ, Dong XH, Wu F, Zhang Y, Li WH, Yang BF, Du WJ. Yu ST, et al. Among authors: pang xc. Acta Pharmacol Sin. 2024 Oct 16. doi: 10.1038/s41401-024-01395-5. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39414959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters